Abstract
Riemerellosis is an infectious disease that primarily affects young ducklings, although it can infrequently be manifested in a chronic localised form in older ducks. Though an inactivated vaccine has been found to be most effective in preventing the disease in ducklings, its potency in adult breeder ducks has not been assessed yet. To investigate the same, 200 Kuttanad breeder ducks maintained in the University Poultry and Duck Farm (UPDF), Mannuthy were grouped into two, of 100 birds each, T1 being the control group and T2, the treatment (vaccinated) group. The oil-adjuvanted inactivated vaccine, prepared as per the previously standardised protocol, was administered to the T2 group in two doses, one week apart. Blood samples in serum vials, 20 each from T1 and T2, were collected on days 0, 14, 28, 56 and 90 post-immunisation (PI) whereas blood samples in heparin vials, eight each from both the groups, were collected on days 0, 14, and 28 PI. Humoral immunity (HI) and cell mediated immunity (CMI) in the adult ducks were assessed by enzyme-linked immunosorbent assay (ELISA) and lymphocyte proliferation assay (LPA), respectively. The two assays revealed that the inactivated vaccine elicited a good immune response in the adult ducks, with HI noticed until 90th day PI and an increasing CMI that peaked on 28th day PI.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
